Health ProductsNotice to Hospitals

Archived – Important Safety Information on Hemodialysis Units and Blood Tubing Sets Incorporating a Transducer Protector – Notice to Hospitals

· Published by Health Canada · Official notice

Details

Alert type: Notice to Hospitals
Category: Medical Device
Issue: Important Safety Information
Audience: Hospitals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Details

Notice about Health Canada advisories

NOTICE TO HOSPITALS - Health Canada Endorsed Important Safety Information on HEMODIALYSIS UNITS AND BLOOD TUBING SETS INCORPORATING A TRANSDUCER PROTECTOR

June 10, 2004

To: Hospital CEO
Hospital Infection Control Practitioners / Department
Provincial and Territorial Ministries of Health
Hemodialysis Departments / Units

Please distribute to the relevant Departments and other involved professional staff and post this NOTICE in your institution.

Subject: Potential for patient to patient cross contamination resulting from hemodialysis treatment

Health Canada has received reports of incidents of blood contamination of internal components of hemodialysis equipment at a number of treatment centres. These reports have raised concerns about patient safety. This problem could result in a minimal risk of patient exposure to blood from patients previously undergoing hemodialysis treatment on the same machine. The cause of the contamination is still being determined and may include many factors, including faulty blood lines and transducer protectors.

The reported cases to date have identified the Baxter Healthcare Corporation's Aurora model and associated blood tubing set. Apparent causes for these cases have yet to be determined but identify the breach of a transducer protector in the disposable blood tubing set used with these units. Health Canada believes that the breach of transducer protectors may not be limited to the Aurora model and that there is the potential for this to occur with all hemodialysis units and blood tubing sets incorporating a transducer protection feature.

Although the potential for patient to patient cross contamination is considered very small, Health Canada's principal concern is the possibility that the equipment cross-contaminated with blood could permit the transfer of blood-borne infectious agents. Therefore, Health Canada strongly recommends that the following actions be taken:

  1. Hemodialysis personnel should verify, after the treatment of each patient, that the transducer protector of the blood set has not been wetted or breached. If wetting or breaching has occurred, then the equipment should be taken out of service and procedures should be followed to thoroughly decontaminate the hemodialysis machine before subsequent use.
  2. All incidents of blood contamination of internal components of hemodialysis equipment should be reported to the manufacturer and Canadian distributer of the equipment and, to Health Canada at the address provided below.

Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 3002C
Ottawa, Ontario K1A 0K9
Tel: The Medical Devices Hotline 1-800-267-9675

For other inquiries: please refer to contact information.

The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada web site.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime